MARKET

RGEN

RGEN

Repligen
NASDAQ
122.59
+2.49
+2.07%
After Hours: 124.98 +2.39 +1.95% 19:28 04/13 EDT
OPEN
119.42
PREV CLOSE
120.10
HIGH
122.97
LOW
118.74
VOLUME
758.14K
TURNOVER
--
52 WEEK HIGH
175.77
52 WEEK LOW
109.66
MARKET CAP
6.91B
P/E (TTM)
141.82
1D
5D
1M
3M
1Y
5Y
1D
1 Cash-Producing Stock Worth Your Attention and 2 We Avoid
Barchart · 5h ago
Weekly Report: what happened at RGEN last week (0406-0410)?
Weekly Report · 21h ago
Repligen: Advancing, Yet Much More Work Ahead
Seeking Alpha · 5d ago
Repligen Price Target Cut to $140.00/Share From $170.00 by Evercore ISI Group
Dow Jones · 04/06 18:01
Evercore ISI Group Maintains Outperform on Repligen, Lowers Price Target to $140
Benzinga · 04/06 17:51
Weekly Report: what happened at RGEN last week (0330-0403)?
Weekly Report · 04/06 10:14
Reassessing Repligen (RGEN) Valuation After Recent Share Price Rebound And Bioprocessing Growth Expectations
Simply Wall St · 04/05 03:26
Repligen publishes 2025 annual report, posts $738 million revenue in 2025
Reuters · 04/03 11:20
More
About RGEN
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.

Webull offers Repligen Corp stock information, including NASDAQ: RGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RGEN stock methods without spending real money on the virtual paper trading platform.